Displaying 41 - 60 of 203 results

NIAMS Seeks Applications for Research Opportunities on HIV/AIDS

https://www.niams.nih.gov/newsroom/announcements/niams-seeks-applications-research-opportunities-hivaids

The HIV/AIDS pandemic and its challenges have a longstanding impact on conditions that fall within the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Responding to this challenge, NIAMS has published a Notice of Special Interest (NOSI) to promote research opportunities on HIV/AIDS (NOT-AR-23-004). Applications are being accepted through January 7, 2028. The NOSI alerts potential applicants to the NIAMS of an area of special interest in HIV/AIDS-associated comorbidities that are within the Institute’s mission. NIH has provided the largest public investment in HIV/AIDS research globally. In line with overall NIH efforts, NIAMS encourages observational

FY 2019 Budget Request

https://www.niams.nih.gov/about/budget/fy2019/annual-statement

FY 2019 Annual Statement to the Appropriations Committee ______________________________________ Mr. Chairman and Members of the Committee: I am pleased to present the President’s Fiscal Year (FY) 2019 budget request for the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH). NIAMS RESEARCH

FY 2012 Budget Request

https://www.niams.nih.gov/about/budget/fy2012/annual-statement

Statement to the Senate Appropriations Subcommittee May 11, 2011 (historical) Stephen I. Katz, M.D., Ph.D., Director National Institute of Arthritis and Musculoskeletal and Skin Diseases _______________________________________ Mr. Chairman and Members of the Committee: I am pleased to present the President’s Fiscal Year 2012 Budget for the National Institute of Arthritis

Donations to NIAMS

https://www.niams.nih.gov/about/budget/donations

Anyone, an individual or an organization, can donate to the NIAMS. The NIAMS is federally funded and not a fundraising organization; but, the U.S. Congress authorizes NIAMS to accept donations and bequests to support the scientific mission of the Institute. Donations to NIAMS are deposited in a NIAMS “Gift Fund”

FY 2016 Budget Request

https://www.niams.nih.gov/about/budget/fy2016/annual-statement

Statement for the Record Senate Subcommittee on Labor-HHS-Education Appropriations June 15, 2015 Stephen I. Katz, M.D., Ph.D., Director National Institute of Arthritis and Musculoskeletal and Skin Diseases _______________________________________ Mr. Chairman and Members of the Committee: I am pleased to present the President’s fiscal year (FY) 2016 budget request for the

FY 2015 Budget Request

https://www.niams.nih.gov/about/budget/fy2015/annual-statement

Statement for the Record Senate Subcommittee on Labor-HHS-Education Appropriations April 2, 2014 Stephen I. Katz, M.D., Ph.D., Director National Institute of Arthritis and Musculoskeletal and Skin Diseases ______________________________________ Mr. Chairman and Members of the Committee: I am pleased to present the President’s Budget request for the National Institute of Arthritis

NIAMS Director Dr. Lindsey Criswell Elected to National Academy of Medicine

https://www.niams.nih.gov/newsroom/announcements/niams-director-dr-lindsey-criswell-elected-national-academy-medicine

The National Academy of Medicine (NAM) has announced that Lindsey A. Criswell, M.D., M.P.H., D.Sc., Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at the National Institutes of Health (NIH), was elected as a member in recognition of her outstanding scientific achievements and commitment to volunteer service.

NIAMS Remembers Scientist Emeritus Paul Plotz, M.D.

https://www.niams.nih.gov/newsroom/announcements/niams-remembers-scientist-emeritus-paul-plotz-md

NIAMS is saddened to share the news that Paul Plotz, M.D., who dedicated nearly four decades of service to science at the NIH, passed away on January 13, 2024, at the age of 86 after a long illness. Dr. Plotz was a world-renowned rheumatologist, immunologist, and researcher known internationally as an expert in myositis, an inflammatory muscle disease and rare autoimmune condition. He retired from NIH in 2011 after serving in a variety of leadership roles, including as chief of the NIAMS Arthritis and Rheumatism Branch, as well as acting scientific director and acting deputy director. He also was senior

From the Deputy Director: Piecing Together the Autoimmune Disease Puzzle

https://www.niams.nih.gov/about/about-the-director/letter/piecing-together-autoimmune-disease-puzzle

In her December 2021 letter, NIAMS Director Dr. Lindsey Criswell discussed the launch of the Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) program. This new initiative builds upon the progress of the prior AMP RA/SLE project, which greatly advanced our understanding of the mechanisms that drive disease in rheumatoid arthritis (RA) and lupus.

Typically materials from NIAMS that are more than 5 years old will be archived.

Back to Top